The global market for research grade proteins is valued at $1.13 billion in 2024, with an expected rise to $1.31 billion in 2025. By 2034, the market is projected to reach approximately $4.81 billion, growing at a compound annual growth rate (CAGR) of 15.57% from 2025 to 2034. This growth is driven by the increasing use of research-grade proteins in a variety of fields, including disease analysis, drug development, and biomedical research, which are fueling high demand.
Download statistics of this report @ https://www.towardshealthcare.com/download-statistics/5397
Research grade proteins are specifically manufactured and purified to high standards for use in scientific research. These proteins are essential in various disciplines such as molecular biology, biochemistry, cell biology, and drug discovery. They are crucial tools for understanding protein structures, functions, and interactions, as well as for developing new treatments. With advancements in proteomics and genomics, expanding drug development applications, and the rise of cutting-edge research technologies, the market is expected to experience significant growth in the coming years.
Recent developments highlight the growing investments and innovations in the field. For instance, in November 2024, Sanofi announced a €40 million (approximately $42 million) investment in its bioproduction facility in Lyon, France, part of which will support research and manufacturing of its polyclonal antibody, Thymoglobulin, used for transplant recipients. Similarly, in May 2024, Allozymes, a leading enzyme engineering company, completed a $15 million Series A funding round, which will help expand its presence in the European market and underscore the increasing interest in novel biotechnologies.
Protein engineering, an emerging field in biotechnology, is revolutionizing multiple industries, including drug development, food security, and environmental sustainability. Advancements in machine learning (ML), particularly through natural language processing (NLP) models and large protein databases, have accelerated the pace of protein engineering. Additionally, new AI-driven techniques, such as those for protein structure prediction (like AlphaFold2), are making structure-based ML-assisted protein engineering more powerful and effective. These innovations are expected to further enhance the potential of research-grade proteins in a range of scientific and medical applications.
Our Table of Content (TOC) covers key healthcare market segments, materials, technologies and trends—helping you navigate market shifts and make informed decisions: https://www.towardshealthcare.com/table-of-content/research-grade-proteins-market-sizing
Access exclusive insight now @ https://www.towardshealthcare.com/price/5397
We’ve prepared a service to support you. Please feel free to contact us at sales@towardshealthcare.com
Web: https://www.towardshealthcare.com
Visit Dental Specifics: https://www.towardsdental.com
Get the latest insights on industry segmentation with our Annual Membership: Get a Subscription
For Latest Update Follow Us: https://www.linkedin.com/company/towards-healthcare
The global thyroid cancer diagnostics market is experiencing steady growth as advancements in medical technologies continue to enhance early detection,… Read More
The global autoimmune disease diagnostics market is poised for significant growth in the coming decade. Market forecasts indicate a surge… Read More
The Europe dermal filler market is witnessing remarkable growth, fueled by rising beauty consciousness, advancements in non-invasive aesthetic procedures, and… Read More
The AI in cancer drugs market is on a remarkable growth path, poised to generate substantial revenue between 2025 and… Read More
The global biostimulants market is on a steady rise. Valued at USD 3.06 billion in 2024, it's expected to grow… Read More
The dental insurance market is booming. In 2024, it was valued at $232.07 billion, grew to $253.72 billion in 2025,… Read More